Prostate cancer: management and controversies.
Advances in the management of prostate cancer are associated with uncertainties and controversies in screening, who and when to treat, the best treatment option for localized disease and what to do with biochemical relapse after presumed curative treatment.
Lee
Frank
F
Institute of Urology and Nephrology, University College London, London W1W 7EY.
Patel
Hitendra R H
HR
D002985:Clinical Protocols; D006801:Humans; D008297:Male; D008403:Mass Screening; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging / Q000379:methods; D010808:Physical Examination / Q000379:methods; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors; D020728:Transurethral Resection of Prostate / Q000379:methods
D017430:Prostate-Specific Antigen